🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,196 results for “GE” Clear

  1. Ferinject 50 mg/ml dispersión inyectable y para perfusión

    The George Institute

    Acute coronary syndrome

    approved small molecule active

    1 trial

  2. Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva

    The George Institute

    Avian influenza and seasonal influenza

    approved small molecule active

    1 trial

  3. Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable

    The George Institute

    Cardiovascular device infections

    approved small molecule active

    1 trial

  4. Fludex 1,5 mg, επικαλυμμένα με λεπτό υμένιο δισκία παρατεταμένης αποδέσμευσης., LUCIDEL 150 mg επικαλυμμένα με λεπτό υμένιο δισκία., Amlopen® 5mg καψάκια σκληρά, Inosamin 25mg, επικαλυμμένα με λεπτό υμένιο δισκία

    The George Institute

    Hypertension

    approved small molecule active

    1 trial

  5. Foliumzuur Aurobindo 5 mg, tabletten, XELJANZ 5 mg film-coated tablets, METHOTREXAAT SANDOZ 2,5 MG, TABLETTEN, Methotrexaat Teva 20,0 mg, Oplossing voor injectie in een voorgevulde pen, Enbrel 50 mg solution for injection in pre-filled syringe, Methotrexaat Teva 25,0 mg, Oplossing voor injectie in een voorgevulde pen, Methotrexaat Teva 15 mg, Oplossing voor injectie in een voorgevulde pen

    Disc Medicine

    Psoriatic arthritis

    approved small molecule active

    1 trial

  6. Fremanezumab Prefilled Syringe [Ajovy]

    Teva Pharma GmbH

    Migraine Disorders

    approved small molecule terminated

    1 trial

  7. GAVRETO ®(pralsetinib) capsules

    RIGEL PHARMACEUTICALS INC

    Patients with advanced or metastatic solid tumors

    approved small molecule active

    1 trial

  8. GEMCITABINE HYDROCHLORIDE, CISPLATIN, AVELUMAB, CISPLATIN, CISPLATIN, CISPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE

    Fondazione Telethon ETS

    metastatic or locally advanced urothelial cancer

    approved small molecule active

    1 trial

  9. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  10. Group C : Saline + propofol group

    Hospital Authority, Hong Kong

    Urologic Surgery

    approved small molecule completed

    1 trial

  11. Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial

  12. HTX-011

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    6 trials

  13. HUMAN SERUM ALBUMIN, SODIUM CHLORIDE

    The George Institute

    descompensated hepatic cirrosis

    approved small molecule active

    1 trial

  14. HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.

    The George Institute

    Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).

    approved small molecule active

    1 trial

  15. HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE

    The George Institute

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  16. Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection

    Disc Medicine

    Congenital Haemophilia A

    approved small molecule active

    1 trial

  17. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  18. High-dosage of COVID-19 vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  19. High-dose anrikefon

    The First People's Hospital of Lianyungang

    Laparoscopic Surgery

    approved small molecule active

    2 trials

  20. Humira 40 mg solution for injection in pre-filled pen, ORENCIA 125 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe, Reumaflex 50 mg/ml soluzione iniettabile, siringa preriempita, ORENCIA 250 mg powder for concentrate for solution for infusion, Cosentyx 150 mg solution for injection in pre-filled syringe, Enbrel 25 mg solution for injection in pre-filled syringe, Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Jylamvo 2 mg/ml oral so

    Istituto Gentili S.r.l.

    Juvenile idiopathic arthritis

    approved small molecule active

    1 trial

  21. INDOCYANINE GREEN

    The George Institute

    Patients with liver tumors that will undergo minimally invasive liver surgery

    approved small molecule active

    1 trial

  22. INDOCYANINE GREEN

    Disc Medicine

    cervical cancer stage I-IIA

    approved small molecule active

    1 trial

  23. INFLIXIMAB, INFLIXIMAB

    Istituto Gentili S.r.l.

    Inflammatory Bowel Disease

    approved small molecule active

    1 trial

  24. INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN

    The George Institute

    Influenza, Immunity against influenza

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources